Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.


CSE:HUGE - Post by User

Comment by DavidRosenbergon Oct 02, 2021 11:30pm
46 Views
Post# 33958261

RE:RE:HUGE Reset

RE:RE:HUGE Reset
Mil_Man54 wrote: Through further dilution of shares on the backs of investors.....their next step was for the CEO, AD, to hire 6 marketing firms at a cost of $2.5M annually plus 219936 shares to hype FSD with nothing to hype......now they have to hire an entire team to even think of beginning any development let alone trials........why aren't you adding this info Rosenberg......it's is relevant and actually factual.....

DavidRosenberg wrote: Is happening now 

lucid was the first proper step.

cheers 




 

I let you fill in those parts mil man whenever I forget to add something 

marketing is needed to remind investors , those that missed the psychedelic train maybe can catch it with FSD if management do the right steps to do something good for shareholders 

not sure how the 2.5 for marketing will work , I don't know if those marketing companies will make a difference , I want to see FSD Pharma ok CNBC talking about lucid drug compounds 

<< Previous
Bullboard Posts
Next >>